Business
Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination
Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed business combination adjourned to Friday, December 3, 2021, at 7:00 a.m.
About this update from P3 Health Partners Inc.
[{"type":"text","content":"Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed business combination adjourned to Friday, December 3, 2021, at 7:00 a.m. Central Time\nNEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ: FORE) (“Foresight”) announced that its Special Meeting of Foresight’s stockholders (the “Special Meeting”) relating to the proposed business combination (the “Business Combination”) with P3 Health Partners (“P3”) that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned until 7:00 a.m. Central Time on December 3, 2021. As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional time to file a proxy supplement to the definitive proxy statement that was filed with the Securities and Exchange Commission (“SEC”) on October 28, 2021 (the “Proxy Statement”) and mailed to Foresight’s stockholders, and to provide Foresight’s stockholders additional time to review and consider the information to be set forth in such proxy supplement. The proxy supplement will contain revised Unaudited Pro Forma Financial Statements reflecting changes related to the previously disclosed determination that the Business Combination should be accounted for as a business combination using the acquisition method of accounting rather than as a reverse recapitalization as currently provided for in the Unaudited Pro Forma Financial Statements contained in the Proxy Statement. As previously disclosed, these changes will have no impact on the historical financial statements of P3 or Foresight that were included in the Proxy Statement. Foresight expects to file the proxy supplement on or about Monday, November 29, 2021. No changes have been made to the record date, the location of the meeting or the proposals to be voted on at the Special Meeting, which are presented in the Proxy Statement filed with the SEC on October 28, 2021. The re-convened meeting will be held virtually at https://www.cstproxy.com/foresightacq/2021. Only the holders of Foresight’s common stock as of the close of business on October 8, 2021, the record date for the Special Meeting, are entitled to vote at the Special Meeting. If you have already submitted your proxy, you do not need to take any action un...